FRINGE

Establish experimental proof-of-principle of the novel neutron-activated therapy

FRINGE proposes a new technology that combines neutron-based therapy and cancer specificity to treat deep lying tumours. At its heart are chemical agents, which preferentially accumulate in the tumours especially in brain cancers and eventually kill the tumour cells.

MAIN THEMES:

Biotech & Health

TOPICS:

Cancer treatmentNeurons

COORDINATING ORGANISATION:

OSLO UNIVERSITETSSYKEHUS HF

WEBSITE:

www.fringe-fetopen.eu/

Stories related to FRINGE project

Related projects

ABIOMATER

Building the next class of metamaterials that will address the present issues in our medical devices and implants

  • FFXicon-result-prototypePrototyping phase

RiboNets

Looking for new ways to cure genetic diseases from the bottom-up by building devices that are based on RNAs

HELICoiD

Allowing doctors to detect cancer cells on the spot while undergoing surgery

  • FFXicon-result-patentRegistered patents
  • FFXicon-result-prototypePrototyping phase

ByAxon

Introducing less-invasive implants that treat spinal cord issues using nanomaterials

  • FFXicon-result-prototypePrototyping phase
Browse all FET projects